XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2019   254,842,949      
Beginning balance at Dec. 31, 2019 $ 334,619 $ 2,548 $ 408,667 $ (23,927) $ (52,669)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 29,669       29,669
Other comprehensive loss (5,076)     (5,076)  
Dividends declared (7,666)       (7,666)
Profit-sharing plan shares, net (in shares)   (186,715)      
Profit‑sharing plan shares, net (1,850) $ (2)     (1,848)
Shares issued in connection with deferred compensation plan, net (in shares)   683,072      
Shares issued in connection with deferred compensation plan, net (301) $ 7     (308)
Deferred compensation plan voluntary contributions 1,003   1,003    
Payment of shareholder Put and Call rights (in shares)   (37,870)      
Payment of shareholder Put and Call rights (302)       (302)
Stock option exercises, net (in shares)   697,833      
Stock option exercises, net (618) $ 6 712   (1,336)
Shares issued for stock grants (in shares)   10,951      
Shares issued for stock grants 119   119    
Stock-based compensation expense 1,653   1,653    
Shares related to restricted stock, net (in shares)   (285,019)      
Shares related to restricted stock, net (240) $ (3) (116)   (121)
Ending balance (in shares) at Mar. 31, 2020   255,725,201      
Ending balance at Mar. 31, 2020 351,010 $ 2,556 412,038 (29,003) (34,581)
Beginning balance (in shares) at Dec. 31, 2020   272,154,504      
Beginning balance at Dec. 31, 2020 341,599 $ 2,722 741,113 (26,233) (376,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 57,006       57,006
Other comprehensive loss (9,161)     (9,161)  
Purchase of capped call options, net of tax of $6,250 (19,430)   (19,430)    
Dividends declared (8,219)       (8,219)
Shares issued in connection with deferred compensation plan, net (in shares)   339,503      
Shares issued in connection with deferred compensation plan, net (8,859) $ 3     (8,862)
Deferred compensation plan voluntary contributions 854   854    
Shares issued in connection with Executive Bonus Plan, net (in shares)   79,961      
Shares issued in connection with Executive Bonus Plan, net 3,537 $ 1 5,573   (2,037)
Stock option exercises, net (in shares)   1,263,121      
Stock option exercises, net (5,407) $ 12 1,739   (7,158)
Stock-based compensation expense 2,786   2,786    
Shares related to restricted stock, net (in shares)   (114,606)      
Shares related to restricted stock, net (709) $ (1)     (708)
Ending balance (in shares) at Mar. 31, 2021   273,722,483      
Ending balance at Mar. 31, 2021 $ 353,997 $ 2,737 $ 732,635 $ (35,394) $ (345,981)